Evidence map›Paper›PMID 36896425›Full record

ArticleFrontiers in microbiology2023

A MALDI-TOF MS library for rapid identification of human commensal gut bacteria from the class

Paul Tetteh Asare, Chi-Hsien Lee, Vera Hürlimann, Youzheng Teo, Aline Cuénod, Nermin Akduman, Cordula Gekeler, Afrizal Afrizal, Myriam Corthesy, Claire Kohout and 8 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. iScience · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 4 countries.

Paul Tetteh AsareDepartment of Fundamental Microbiology, University of Lausanne, Lausanne, Switzerland.
Chi-Hsien LeeDepartment of Fundamental Microbiology, University of Lausanne, Lausanne, Switzerland.
Vera HürlimannDepartment of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland.
Youzheng TeoDepartment of Fundamental Microbiology, University of Lausanne, Lausanne, Switzerland.
Aline CuénodApplied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
Nermin AkdumanInterfaculty Institute of Microbiology and Infection Medicine Tübingen, University of Tübingen, Tübingen, Germany.
Cordula GekelerInterfaculty Institute of Microbiology and Infection Medicine Tübingen, University of Tübingen, Tübingen, Germany.
Afrizal AfrizalFunctional Microbiome Research Group, Institute of Medical Microbiology, RWTH University Hospital, Aachen, Germany.
Myriam CorthesyInstitute of Microbiology of the University of Lausanne, University Hospital Centre (CHUV), Lausanne, Switzerland.
Claire KohoutDuchossois Family Institute, Division of Infectious Diseases and Global Health, University of Chicago, Chicago, IL, United States.
Vincent ThomasBioAster, Paris, France.
Tomas de WoutersPharmaBiome AG, Schlieren, Switzerland.
Gilbert GreubInstitute of Microbiology of the University of Lausanne, University Hospital Centre (CHUV), Lausanne, Switzerland.
Thomas ClavelFunctional Microbiome Research Group, Institute of Medical Microbiology, RWTH University Hospital, Aachen, Germany.
Eric G PamerDuchossois Family Institute, Division of Infectious Diseases and Global Health, University of Chicago, Chicago, IL, United States.
Adrian EgliApplied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
Lisa MaierInterfaculty Institute of Microbiology and Infection Medicine Tübingen, University of Tübingen, Tübingen, Germany.
Pascale VonaeschDepartment of Fundamental Microbiology, University of Lausanne, Lausanne, Switzerland.
Swiss Tropical and Public Health Institute · CHUniversity of Lausanne · CHUniversity of Tübingen · DEUniversitätsklinikum Aachen · DEUniversity of Basel · CHUniversity of Chicago · USBIOASTER · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Microbial isolates from culture can be identified using 16S or whole-genome sequencing which generates substantial costs and requires time and expertise. Protein fingerprinting Methods: We constructed a database containing mass spectral profiles (MSP) from 142 bacterial strains representing 47 species and 21 genera within the class Results: For validation, we used 58 sequence-confirmed strains and the CLOSTRI-TOF database successfully identified 98 and 93% of the strains, respectively, in two independent laboratories. Next, we applied the database to 326 isolates from stool of healthy Swiss volunteers and identified 264 (82%) of all isolates (compared to 170 (52.1%) with the Bruker-Daltonics library alone), thus classifying 60% of the formerly unknown isolates. Discussion: We describe a new open-source MSP database for fast and accurate identification of the

Indexed as

anaerobicbacterial identificationClostridiacommensal bacteriaculturomicshuman gut microbiotaMALDI-TOF MSnext-generation probiotics

Identifiers

PMID36896425
PMCPMC9990839
OpenAlexW4321458998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.